title: Reply.
authors.affiliation: Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. Electronic address: ragnheib@medisin.uio.no.
authors.forename: Ragnheiður
authors.initials: R
authors.lastname: Bragadóttir
authors.affiliation: Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
authors.forename: Karina
authors.initials: K
authors.lastname: Berg
authors.affiliation: Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
authors.forename: Terje R
authors.initials: TR
authors.lastname: Pedersen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized